Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A bioinformatics approach for precision medicine off-label drug drug selection among triple negative breast cancer patients

23 Apr 2016

Abstract excerpt

BACKGROUND: Cancer has been extensively characterized on the basis of genomics. The integration of genetic information about cancers with data on how the cancers respond to target based therapy to help to optimum cancer treatment. OBJECTIVE: The increasing usage of sequencing technology in cancer research and clinical practice has enormously advanced our understanding of cancer mechanisms. The cancer precision...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Colorectal Cancer Treatments and Studies
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27107440
DOI: 10.1093/jamia/ocw004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 13 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A bioinformatics approach for precision medicine off-label drug drug selection among triple negative breast cancer patientsPMID 27107440Read ↗

The Precision Medicine: Advancement and Transformation in Cancer TreatmentSemantic proximity Read ↗

Personalized cancer therapy-leveraging a knowledge base for clinical decision-making.Semantic proximity Read ↗

Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?Semantic proximity Read ↗

Technological advances in clinical individualized medication for cancer therapy: from genes to whole organismSemantic proximity Read ↗

Systematic identification of drug-based prognostic biomarkersby integrating multiomics in breast cancerSemantic proximity Read ↗

DBPOM: a comprehensive database of pharmaco-omics for cancer precision medicineSemantic proximity Read ↗

Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural ProductsSemantic proximity Read ↗

Integrative Statistical Inferences for Drug Sensitivity Biomarkers in CancerSemantic proximity Read ↗

Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products.Semantic proximity Read ↗

Pharmacogenomics in Tailoring First-Line Therapy for Breast Cancer: PharmGKB Database InsightsSemantic proximity Read ↗

The precise chemotherapy guided by the expression of ERCC1, RRM1, TUBB3, TYMS and TOP2A genes versus the classic chemotherapy in the treatment of breast cancer: a comparative effectiveness researchSemantic proximity Read ↗

Making Sense of Genetic Information: The Promising Evolution of Clinical Stratification and Precision Oncology Using Machine Learning.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.